Lupin launches generic nystatin, triamcinolone acetonide cream

Press enter to search
Close search
Open Menu

Lupin launches generic nystatin, triamcinolone acetonide cream

By Sandra Levy - 11/30/2018
Lupin has launched nystatin and triamcinolone acetonide cream 100,000 units/gm 0.1 %, having received an approval from the Food and Drug Administration earlier.

Lupin’s nystatin and triamcinolone acetonide cream is the generic of Taro Pharmaceuticals’ nystatin and triamcinolone acetonide cream.

The product is indicated for the treatment of cutaneous candidiasis.

Nystatin and triamcinolone acetonide cream had a market value of $54.3 million, according to September 2018 IQVIA data.

RELATED TOPICS